-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/executive-summary-2017-schizophrenia-adult.pdf
January 01, 2017 - .
8
Harms Outcomes
Although SGAs have somewhat differing adverse event
profiles, the evidence indicates … Our network meta-analysis of 90 trials
indicates that risperidone LAI had significantly lower risk … Similarly, evidence indicates a higher rate of
withdrawal from study (and treatment) due to adverse … Evidence on FGAs versus SGAs indicates that
olanzapine, risperidone, ziprasidone, and aripiprazole were
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-test_executive.pdf
April 01, 2013 - An AUC of 1.0 indicates a perfect
test, and an AUC of 0.5 indicates a worthless test.
4
matching
-
effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1506.pdf
June 01, 2015 - PEPTIC ULCER #11
AHRQ Healthcare Horizon Scanning System – Potential
High-Impact Interventions Report
Priority Area 11: Peptic Ulcer Disease and Dyspepsia
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
540 Gaither Road
Rockville, MD 20850
ww…
-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1506.pdf
June 01, 2015 - #05 DEPRESSION
AHRQ Healthcare Horizon Scanning System – Potential
High-Impact Interventions Report
Priority Area 05: Depression and Other Mental Health
Disorders
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
540 Gaither Road
Rockville, MD…
-
effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1506.pdf
June 01, 2015 - #14 SUBSTANCE ABUSE
AHRQ Healthcare Horizon Scanning System – Potential
High-Impact Interventions Report
Priority Area 14: Substance Abuse
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
540 Gaither Road
Rockville, MD 20850
www.ahrq.…
-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1306.pdf
October 01, 2014 - #05 DEPRESSION
AHRQ Healthcare Horizon Scanning System – Potential
High-Impact Interventions Report
Priority Area 05: Depression and Other Mental Health
Disorders
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
540 Gaither Road
Rockville, MD …
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/tonsillectomy_research-protocol.pdf
February 10, 2016 - Source: www.effectivehealthcare.ahrq.gov
Published online: November 9, 2015
Evidence-‐‑based
Practice
Center
Systematic
Review
Protocol
Project Title: Tonsillectomy for Obstructive Sleep-Disordered Breathing or Recurrent Throat Infection
in Children
Initial publication date if applicable…
-
effectivehealthcare.ahrq.gov/sites/default/files/depression_hi_impact.pdf
October 01, 2014 - #05 DEPRESSION
AHRQ Healthcare Horizon Scanning System – Potential High
Impact Interventions Report
Priority Area 05: Depression and Other Mental Health
Disorders
Potential High Impact Interventions Report
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Huma…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/key-informant-interviews-research.pdf
December 19, 2017 - Discerning the Perception and Impact of Patients Involved in Evidence-based Practice Center Key Informant Interviews
Research White Paper
Discerning the Perception and Impact of Patients
Involved in Evidence-based Practice Center Key
Informant Interviews
Researc…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label-update_executive.pdf
September 01, 2011 - Layout 1
Background
Antipsychotics medications are approved
by the U.S. Food and Drug Administration
(FDA) for treatment of schizophrenia and
bipolar disorder. These medications are
commonly divided into two classes,
reflecting two waves of historical
development: the conventional
antipsychotics and the atypical. T…
-
effectivehealthcare.ahrq.gov/sites/default/files/prostatic-hyperplasia-medications_disposition-comments.pdf
May 26, 2016 - Bolded medications “are the medications that are the focus of
this review” whereas on the top, bolded indicates
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/peripheral-artery-disease-treatment_disposition-comments.pdf
May 29, 2013 - Table 3 indicates that the
inclusion criteria for Key Question 2 are exercise
training versus medications
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/sleep-apnea_disposition-comments.pdf
October 25, 2011 - the study by Smith
et al, Ann Intern Med 1985; 103:850 have met
study inclusion criteria, the study indicates … developed a staging system based on
tonguepalate position, tonsil size and body mass
index (BMI), that indicates
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy_disposition-comments.pdf
March 11, 2010 - Would it be more
accurate to say the reference test is the one where the best
evidence indicates it
-
effectivehealthcare.ahrq.gov/sites/default/files/s158.pdf
October 01, 2007 - OR indicates odd ratio; CI, confidence interval; AUC, area under the receiver operating characteristic
-
effectivehealthcare.ahrq.gov/products/cancer-end-of-life-indicators-symposium/research
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-neuropathy_research-protocol.pdf
September 01, 2016 - Transparency of Reporting Requirements: Effectiveness of Treatments Options for the Prevention of Complications and Treatment of Symptoms of Diabetic Peripheral Neuropathy
Source: www.effectivehealthcare.ahrq.gov
Published online: September 1, 2016
Evidence-based Practice Center Methodology Repor t Pr…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/lifecycle-assessment-disposition-comments.pdf
November 20, 2024 - The title indicates that this
is about LCA and health care waste (presumably
solid waste, though this
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/selecting-evidence.ppt
January 01, 2010 - AHRQ Slide Template 2009
When To Select Observational Studies as Evidence for Comparative Effectiveness Reviews
Prepared for:
The Agency for Healthcare Research and Quality (AHRQ)
Training Modules for Systematic Reviews Methods Guide
www.ahrq.gov
When To Select Observational Studies as Evidence for Comparative Eff…
-
effectivehealthcare.ahrq.gov/sites/default/files/selecting-evidence.ppt
January 01, 2010 - AHRQ Slide Template 2009
When To Select Observational Studies as Evidence for Comparative Effectiveness Reviews
Prepared for:
The Agency for Healthcare Research and Quality (AHRQ)
Training Modules for Systematic Reviews Methods Guide
www.ahrq.gov
When To Select Observational Studies as Evidence for Comparative Eff…